• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Compliance with the guidelines of the European Society of Cardiology and morbidity and mortality from infectious endocarditis.

作者信息

Rodríguez Esteban M, Carballo Arzola L, Miranda Montero S, Farrais Villalba M, Medina García J A, Ode Febles J

机构信息

Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España.

Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España.

出版信息

Rev Clin Esp (Barc). 2016 Jan-Feb;216(1):15-8. doi: 10.1016/j.rce.2015.07.008. Epub 2015 Sep 19.

DOI:10.1016/j.rce.2015.07.008
PMID:26390835
Abstract

OBJECTIVE

The antibiotic treatment recommended for infectious endocarditis (IE) has a low level of evidence. Our objective was to determine whether compliance with the recommendations of the European Society of Cardiology (ESC) was related to lower inhospital morbidity and mortality for this disease.

METHODS

A retrospective study was conducted on 162 cases of IE diagnosed between 2005 and 2014. A propensity score-matching analysis was performed to determine the effect of treatment on hospital mortality.

RESULTS

There were no differences in terms of disease complications between the treatment groups. Hospital mortality was 29.2% when the treatment was adjusted to the guidelines and 28.2% when the treatment was not adjusted (OR=1.048; 95%CI: 0.442-2.484; P=.916).

CONCLUSION

The use of the ESC guidelines does not appear to translate into a reduction in hospital morbidity and mortality due to IE when compared with alternative antibiotic treatment regimens.

摘要

相似文献

1
Compliance with the guidelines of the European Society of Cardiology and morbidity and mortality from infectious endocarditis.
Rev Clin Esp (Barc). 2016 Jan-Feb;216(1):15-8. doi: 10.1016/j.rce.2015.07.008. Epub 2015 Sep 19.
2
Implementation of the 2015 European Society of Cardiology guidelines for the management of infective endocarditis in the Netherlands.2015年欧洲心脏病学会感染性心内膜炎管理指南在荷兰的实施情况。
Neth Heart J. 2020 Dec;28(12):628-636. doi: 10.1007/s12471-020-01489-9.
3
[Clinical guidelines for the prevention of infective endocarditis].[感染性心内膜炎预防临床指南]
An Pediatr (Barc). 2014 Mar;80(3):187.e1-5. doi: 10.1016/j.anpedi.2013.02.012. Epub 2013 Apr 2.
4
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry.ESC-EORP EURO-ENDO(欧洲感染性心内膜炎)注册研究。
Eur Heart J Qual Care Clin Outcomes. 2019 Jul 1;5(3):202-207. doi: 10.1093/ehjqcco/qcz018.
5
Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands.2009 年欧洲心脏病学会指南更新后感染性心内膜炎发病率的增加:荷兰全国性研究。
Eur Heart J Qual Care Clin Outcomes. 2017 Apr 1;3(2):141-147. doi: 10.1093/ehjqcco/qcw039.
6
[Infective endocarditis: what's new? European Society of Cardiology (ESC) Guidelines 2009 on the prevention, diagnosis and treatment of infective endocarditis].[感染性心内膜炎:有哪些新进展?欧洲心脏病学会(ESC)2009年感染性心内膜炎预防、诊断和治疗指南]
Presse Med. 2010 Jun;39(6):704-9. doi: 10.1016/j.lpm.2010.03.003.
7
Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.感染性心内膜炎的预防:美国心脏协会指南:美国心脏协会风湿热、心内膜炎及川崎病委员会、青年心血管疾病理事会、临床心脏病学理事会、心血管外科和麻醉理事会以及医疗质量与结果研究跨学科工作组发布的指南
J Am Dent Assoc. 2008 Jan;139 Suppl:3S-24S. doi: 10.14219/jada.archive.2008.0346.
8
Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.感染性心内膜炎的预防:美国心脏协会指南:美国心脏协会风湿热、心内膜炎及川崎病委员会、青年心血管疾病理事会、临床心脏病学理事会、心血管外科与麻醉理事会以及医疗质量与结果研究跨学科工作组发布的指南
J Am Dent Assoc. 2007 Jun;138(6):739-45, 747-60. doi: 10.14219/jada.archive.2007.0262.
9
Adherence to 2015 ESC Guidelines for the Treatment of Infective Endocarditis: A Retrospective Multicentre Study (LEIOT Study).遵循2015年欧洲心脏病学会感染性心内膜炎治疗指南:一项回顾性多中心研究(LEIOT研究)
Antibiotics (Basel). 2023 Apr 4;12(4):705. doi: 10.3390/antibiotics12040705.
10
Temporal changes in infective endocarditis guidelines during the last 12 years: High-level evidence needed.过去12年感染性心内膜炎指南的时间变化:需要高级别证据。
Am Heart J. 2017 Nov;193:70-75. doi: 10.1016/j.ahj.2017.07.018. Epub 2017 Aug 2.

引用本文的文献

1
[Evolution of antimicrobial resistance and mortality in Staphylococcus aureus endocarditis during 15 years in a university hospital].[一所大学医院15年间金黄色葡萄球菌性心内膜炎的抗菌药物耐药性演变及死亡率]
Rev Esp Quimioter. 2021 Apr;34(2):100-106. doi: 10.37201/req/103.2020. Epub 2021 Jan 25.